LHRH analogs for human mammary carcinoma

This publication has 13 references indexed in Scilit:

• TREATMENT WITH A LUTEINISING-HORMONE-RELEASING-HORMONE ANALOGUE (BUSERELIN) IN PREMENOPAUSAL PATIENTS WITH METASTATIC BREAST CANCER
  The Lancet, 1982
• Treatment of Primary Breast Cancer with Chemotherapy and Tamoxifen
  New England Journal of Medicine, 1981
• Effect of Hypophysectomy and Hormone Replacement on Hormone Receptor Levels and the Growth of 7,12 Dimethylbenz(a)anthracene-Induced Mammary Tumors in the Rat*
  Endocrinology, 1980
• Comparison of tamoxifen and hypophysectomy in breast cancer treatment
  Cancer, 1980
• Transsphenoidal hypophysectomy in breast cancer.Evidence for an individual role of pituitary and gonadal hormones in supporting tumor growth.
  Cancer, 1979
• A comparative trial of transsphenoidal hypophysectomy and estrogen suppression with aminoglutethimide in advanced breast cancer
  Cancer, 1979
• Anti-tumour activity of ICI 118630, a new potent luteinizing hormone-releasing hormone agonist
  British Journal of Cancer, 1979
• Current status of estrogen and progesterone receptors in breast cancer
  Cancer, 1977
• Endocrine-Dependent Rat Mammary Tumor Regression: Use of a Gonadotropin Releasing Hormone Analog
  Science, 1976
• ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1
  The Lancet, 1896